The myth-busts, hot takes, explainers, and tools worth keeping.
⚡Myth Buster· 3
⚡Myth Buster07:30
Why Haver Says Menopause Extends Beyond Hot Flashes
Haver argues that menopause has been framed too narrowly around hot flashes, night sweats, and periods. She attributes a much broader range of musculoskeletal, genitourinary, cognitive, mental-health, skin, hair, and other changes to declining ovarian hormones and widespread estrogen receptors. The episode does not independently verify every listed association or show that menopause explains any particular person's symptom.
Haver says estrogen receptors occur across organ systems
She lists brain fog, joint pain, genital and urinary changes, and sleep disruption
She also mentions vertigo, tinnitus, and frozen shoulder as emerging discussion areas
She says validation matters because many patients have previously felt dismissed
Other conditions can resemble or coexist with menopause
“there are estrogen receptors in every organ system of our body”
“they've been dismissed for so long and told it's all in their head”
#menopause symptoms#estrogen#brain fog#joint pain
⚡Myth Buster46:00
How Haver Reinterprets the Women's Health Initiative HRT Scare
Haver says the Women's Health Initiative's estrogen-plus-progestin arm found an increase from four to five breast-cancer cases per thousand women per year, which became a 25 percent relative-risk headline. She argues that public reporting blurred the combined treatment with estrogen alone and says the estrogen-only arm did not show the same increase. These are Haver's figures and interpretation; the episode does not identify formulations, participant details, confidence intervals, or current guideline language sufficiently for individual decisions.
The trial recruited an older population because cardiovascular outcomes were central
Women with a uterus received estrogen plus a progestin in the described arm
Haver contrasts one additional case per thousand with a 25 percent relative increase
She says the estrogen-only arm had a different breast-cancer result
The discussion illustrates why absolute and relative risk should both be reported
“the absolute risk went from four out of a thousand women per year to five out of a thousand”
“That is a 25% relative risk increase.”
#women's health initiative#breast cancer#hrt#risk communication
⚡Myth Buster1:03:00
Why Haver Rejects a Direct Male Equivalent to Menopause
Haver says men's testosterone generally follows a gradual age-related pattern rather than the ovarian transition experienced in menopause. She acknowledges wide testosterone variation between men and reports that some men feel better with supplementation, while stressing that male hormone care is not her specialty. The episode does not provide enough evidence to evaluate testosterone treatment benefits or risks.
Haver describes a gradual testosterone decline rather than an abrupt reproductive endpoint
She says normal testosterone levels vary widely between men
She rejects the term manopause as a biological equivalent
Her comments on male supplementation are outside her stated speciality
The segment should not be used to infer treatment need from age alone
“The short answer is not really.”
“there is no manopause”
#testosterone#male ageing#menopause#hormones
◆Hot Take· 1
◆Hot Take59:00
Why Haver Sees Long-Distance Menopause Care as a System Failure
Haver says her clinic has a very long waiting list and that patients regularly fly in because they cannot find suitable menopause care locally. She calls that trust an honour but the underlying access problem ridiculous. She points listeners toward a provider list on her own website and a certified-provider directory from The Menopause Society, while the episode does not assess either directory's coverage or quality controls in depth.
Patients reportedly travel long distances to Haver's clinic
She treats demand as evidence of a local care-access gap
Her website compiles providers recommended by followers
The Menopause Society also maintains a certified-provider directory
A directory listing is not itself proof that a clinician fits every patient's needs
“women are flying in regularly to come and see me”
“it's ridiculous that they can't find menopause care in their backyard”
#healthcare access#menopause clinic#provider directory#women's health
✶Explainer· 7
✶Explainer09:00
Perimenopause, Menopause, and Postmenopause Are Not the Same Stage
Haver defines menopause as the point reached after 12 months without a period in someone over 45, while postmenopause is the time thereafter. She describes perimenopause as a potentially long and irregular transition in which hormone patterns and periods can change unpredictably. She notes that hysterectomy, an IUD, or other reasons for absent bleeding can make assessment less straightforward.
Haver gives 51 as the average menopause age in the US and much of Europe
She says perimenopause can begin seven to ten years earlier
She calls the changing cycles of perimenopause the zone of chaos
Menopause itself is a retrospective milestone rather than a prolonged stage
Blood work may help when menstrual history cannot be used
“I call it the zone of chaos.”
“menopause itself is really that it's just really one day in your life”
#perimenopause#menopause#hormones#menstrual cycle
✶Explainer21:00
The Long-Term Health Risks Haver Associates with Menopause
Haver says research treats menopause as an independent contributor, alongside ageing, to increased cardiovascular disease, diabetes, insulin resistance, bone loss, and other health burdens. She also claims early hormone therapy may reduce some risks and that benefits diminish when started later. These are her summaries of unspecified studies; the transcript does not provide enough detail to assess effect sizes, causality, or individual treatment decisions.
Haver distinguishes ageing from menopause as overlapping influences
She reports increased cardiovascular and diabetes risk after menopause
She describes a window near perimenopause and the first ten postmenopausal years
She characterises estrogen as better at prevention than cure
The episode does not identify the underlying studies or absolute risks
“when you add in menopause as an independent risk factor, her risk for cardiovascular disease increases”
“estrogen is better at prevention than cure”
#cardiovascular risk#diabetes#estrogen#hrt
✶Explainer31:00
How Haver Connects Menopause with Mental-Health Changes
Haver says depression, anxiety, bipolar disorder, and ADHD can newly appear or worsen during the menopause transition. She describes estrogen as an adjunctive consideration rather than primary treatment for depression and says existing psychiatric medication may need clinical review if symptoms change. Her claims about prevention, incidence, and suicidality are reported from the interview and are not independently established by the transcript.
Haver describes both new onset and worsening of existing conditions
She explicitly says no one is advocating estrogen as primary depression therapy
She says hormone therapy may be an adjunct in some clinical contexts
She reports an observed suicide-rate increase in some US perimenopausal women
Any medication changes require appropriate clinical care
“we see either a new onset or worsening of disease”
“no one right now is advocating for primary therapy of depression to be estrogen replacement”
#mental health#depression#anxiety#adhd
✶Explainer49:30
The Genitourinary Symptoms Haver Says Are Often Missed
Haver describes genitourinary syndrome of menopause as changes affecting the bladder, vagina, and surrounding tissue after estrogen declines. She links it with dryness, painful sex, reduced elasticity, and recurrent urinary tract infections, then strongly advocates local vaginal estrogen. Her broad safety statement, including use in breast-cancer patients, is a claim in the episode and requires individual specialist guidance rather than being treated as universal advice.
Haver says the affected tissues contain many estrogen receptors
She lists dryness, painful intercourse, and recurrent urinary infections
She distinguishes local vaginal treatment from systemic hormone therapy
She presents vaginal estrogen as underused
The transcript does not discuss product labels, cancer subtypes, contraindications, or shared decision-making detail
“we lose elasticity, we see recurrent urinary tract infections”
“It's not absorbed systemically.”
#genitourinary syndrome#vaginal estrogen#uti#sexual health
✶Explainer51:00
Local, Systemic, Oral, and Transdermal HRT Explained
Haver distinguishes local vaginal estrogen from systemic therapy intended to reach multiple body systems. She lists pills, gels, creams, patches, rings, and pellets, noting that common choices differ between the UK and US. She says oral estrogen passes through the liver and can raise clotting factors, while non-oral routes bypass that first-pass pathway; this is her clinical explanation, not a complete prescribing guide.
Local treatment targets nearby genitourinary tissue
Systemic treatment is intended to affect the body more broadly
UK prescribing commonly uses gel or cream in Haver's account
US non-oral prescribing commonly uses a patch in her account
Route choice depends on individual risks, formulation, access, and clinician judgement
“we have oral and non-oral medication”
“if they avoid oral estrogen and go with a non-oral form, then we bypass the liver”
#hrt#estrogen#transdermal patch#medication routes
✶Explainer54:30
What Haver Checks Before Attributing Symptoms to Menopause
Haver says she starts by hearing the patient's story, reviewing symptoms, and sometimes using hormone tests when the menopause stage is unclear. She also checks for thyroid problems, autoimmune disease, nutritional deficiencies, and basic blood or electrolyte abnormalities that could resemble or compound menopause. This is a description of her practice, not a standard test panel for every patient.
The patient's symptom story comes before testing
Hormone testing may be useful when periods cannot clarify the stage
Fatigue, night sweats, and weight change can have non-menopausal explanations
Haver mentions thyroid, autoimmune, vitamin D, blood-count, and electrolyte checks
Testing should be selected for the individual's history and presentation
“I start by letting you tell your story.”
“I want to make sure I'm not missing something else that looks a lot like perimenopause.”
Why Loss of Desire Is Not the Only Sexual-Health Question
Haver separates several possible contributors to female sexual difficulties, including relationship problems, arousal, orgasm, and desire. She says treatment depends on the relevant cause and discusses testosterone and prescription medicines as possible options for some desire concerns. The conversation is incomplete as a diagnostic model and does not establish eligibility, efficacy, or safety for any individual.
Relationship distress may not be corrected by medication
Arousal difficulty is distinct from lack of desire
Orgasmic difficulty is another separate concern
Haver says menopause can reduce desire even in a secure relationship
Medication choices require a clinician and may differ by country and regulatory approval
“there's kind of five buckets why a woman would be suffering or not happy”
“that desire to initiate, that desire, yes, this seems like a good idea. That goes away with menopause a lot.”
#sexual health#desire#arousal#menopause
❝Story· 2
❝Story16:00
The Training Culture Haver Says Taught Doctors to Dismiss Women
Haver recalls receiving only about six hours of menopause teaching during a four-year residency and describes a derogatory code used by senior residents for midlife patients with multiple complaints. She now interprets many of those patients as potentially perimenopausal and says her own limited training made her a poor menopause provider for years. This is her account of one training culture, not evidence that every clinician or programme behaves the same way.
Menopause complaints were grouped into general gynaecology rather than a dedicated clinic
Haver says senior residents informally called some patients whiny women
She links dismissal partly to clinicians feeling unable to help
She acknowledges relying on inherited training for roughly 15 years
Her story illustrates how vague multi-system symptoms can be psychologised
“I was a horrible menopause provider for probably 15 years.”
How Losing Three Brothers Shaped Haver's Health Mission
Haver recounts losing three brothers after serious illnesses and says caring for one brother at the end of his life coincided with her own unrecognised menopause. She initially attributed sleep, mental-health, and brain-fog changes entirely to grief. Her family history now motivates her personal focus on nutrition, exercise, sleep, stress reduction, and clinical choices so she can maximise her chance of seeing her daughters grow older.
One brother died from childhood leukaemia after a later relapse
Another lived with HIV, hepatitis, and alcoholism before his death
A third died after stage-four oesophageal cancer
Haver says grief led her to dismiss her own menopause symptoms
Her longevity motivation is personal rather than a promised medical outcome
“in my rush to deliver his care I forgot my own”
“I want to see my grandkids one day.”
#grief#family history#motivation#caregiving
?Q&A· 1
?Q&A53:00
The HRT Side Effects Haver Watches During Treatment
Haver says estrogen therapy can be associated with headaches or worsening migraines and that menopausal hormone therapy can cause vaginal bleeding. She also describes adhesive reactions with patches and says formulation and dose may require trial and error. The percentages she gives are interview claims, and persistent bleeding or other concerning symptoms require clinical assessment rather than reassurance from the episode.
Haver treats headaches and worsening migraines as reasons for caution
She reports vaginal bleeding in some patients on therapy
She says persistent bleeding may prompt ultrasound assessment
Patch adhesive can cause a skin reaction in some users
Alternative formulations and doses may be considered with a prescriber
“40% of patients on menopausal hormone therapy will have vaginal bleeding”
“we have to do some trial and error”
#hrt side effects#migraine#vaginal bleeding#patch allergy